Detalhe da pesquisa
1.
Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
Breast Cancer Res Treat
; 138(1): 47-57, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23338761
2.
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Nat Genet
; 31(1): 55-9, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11967536
3.
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
Breast Cancer Res Treat
; 133(3): 843-51, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21748294
4.
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes.
Breast Cancer Res Treat
; 132(2): 439-48, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21614566
5.
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.
Proc Natl Acad Sci U S A
; 105(35): 13021-6, 2008 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-18755890
6.
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
PLoS Genet
; 4(4): e1000054, 2008 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-18437204
7.
Association of rare MSH6 variants with familial breast cancer.
Breast Cancer Res Treat
; 123(2): 315-20, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19924528
8.
Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition.
Breast Cancer Res Treat
; 119(2): 399-407, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19876732
9.
Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.
Breast Cancer Res Treat
; 122(1): 125-33, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19763817
10.
Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.
Breast Cancer Res Treat
; 124(3): 635-41, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20191381
11.
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines.
Breast Cancer Res Treat
; 121(1): 53-64, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19593635
12.
CHEK2 1100delC and male breast cancer in the Netherlands.
Breast Cancer Res Treat
; 116(2): 397-400, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18759107
13.
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines.
Breast Cancer Res Treat
; 113(2): 285-91, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18297428
14.
Molecular profiles of progesterone receptor loss in human breast tumors.
Breast Cancer Res Treat
; 114(2): 287-99, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18425577
15.
Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update.
Breast Cancer Res Treat
; 114(1): 127-35, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18483851
16.
Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer.
Breast Cancer Res Treat
; 116(2): 263-71, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18629630
17.
Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
Breast Cancer Res Treat
; 113(2): 275-83, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18311582
18.
Low-risk susceptibility alleles in 40 human breast cancer cell lines.
BMC Cancer
; 9: 236, 2009 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19607694
19.
CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer.
Clin Cancer Res
; 14(15): 4989-94, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18676774
20.
Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response.
Clin Cancer Res
; 14(17): 5555-64, 2008 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18765548